Search Cancer Articles
Find the Latest Cancer Research & News
Search results
Displaying 1 - 20 of 1660
Cancer,
Science & Research
Over 3 dozen UCLA faculty ranked among the world’s most influential researchers
In a testament to UCLA research that transforms lives across the globe, 39 faculty members have been named among the world’s most influential scholars in the sciences and social sciences — a distinction reserved for only one out of every thousand researchers.
November 14, 2025
|
2 min read
Cancer,
Science & Research
New therapy delays progression of recurrent prostate cancer
Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy went more than twice as long without their disease worsening compared with those who received SBRT alone.
November 12, 2025
|
5 min read
Cancer,
Science & Research
UCLA researchers awarded funding for cancer research center at the VA
Dr. Matthew Rettig has been awarded a grant from the U.S. Department of Veterans Affairs to establish a new clinical cancer research center that will expand access to precision oncology clinical trials for veterans across the Southwest United States.
November 10, 2025
|
2 min read
Cancer,
Science & Research
Detecting heart issues in breast cancer survivors
November 4, 2025
|
3 min read
Cancer,
Science & Research
UCLA Health Cardio-Oncology Program recognized as Center of Excellence by Becker’s Oncology
The Gold Status designation is the highest level of certification awarded by the global organization and recognizes programs that demonstrate the highest standards of care in the cardio-oncology field.
November 3, 2025
|
2 min read
Cancer,
Science & Research
UCLA awarded NIH grant to launch surgeon-scientist training program to advance cancer research
The program is designed to help the next generation of surgeon-scientists bridge the gap between the operating room and the research lab, accelerating innovations that improve treatments and outcomes for people with cancer.
November 3, 2025
|
2 min read
Cancer,
Science & Research
DNA copy-number changes help melanoma develop resistance to immunotherapy, UCLA study finds
A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin cancer, evolves to resist immunotherapy and identifies a potential strategy to prevent or reverse that resistance.
October 31, 2025
|
4 min read
Cancer
What you should know about lung cancer risk, screening and treatment
October 30, 2025
|
6 min read
Cancer,
Science & Research
Adding chemotherapy to radiation causes greater short-term decline in quality of life for patients with cervical cancer
A new study co-led by investigators at UCLA Health found that women with early-stage cervical cancer who received radiation plus chemotherapy reported a greater short-term decline in quality of life compared to those who received radiation alone.
October 22, 2025
|
3 min read
Cancer,
Science & Research
UCLA scientists develop one-product-fits-all immunotherapy for breast cancer
UCLA researchers have developed a CAR-NKT cell therapy that has shown to be more effective than current immunotherapies at fighting cancer in tumor samples from late-stage triple-negative breast cancer patients.
October 21, 2025
|
4 min read
Cancer,
Science & Research
Dr. Antoni Ribas recognized for transforming cancer treatment
Dr. Ribas was named the 17th Annual Weinman Award recipient in recognition of his pioneering research that led to the development of novel and effective therapies for patients with metastatic melanoma, a disease once considered untreatable.
October 21, 2025
|
2 min read
Cancer,
Healthy Lifestyle
UCLA Health brings world-class cancer care to Guam through new partnership
October 20, 2025
|
4 min read
Cancer,
Science & Research
Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer
A new study led by UCLA found that combining zanzalintinib and atezolizumab helped patients with metastatic colorectal cancer live longer and control their disease better than with the standard treatment drug regorafenib.
October 20, 2025
|
4 min read
Cancer,
Science & Research
ESMO: 10-year survival data for lung cancer immunotherapy, new PSMA-targeted therapy for recurrent prostate cancer, promising results in metastatic colorectal and urothelial cancers
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will present new research at the ESMO Congress, covering advances in immunotherapy, targeted therapies, and new combination therapies for aggressive and hard-to-treat cancers.
October 19, 2025
|
3 min read
Cancer,
Science & Research
Dr. Jingran Ji receives NIH GEMSSTAR award to advance research in cancer and aging
The award will support Ji’s research into how cancer treatments affect physical function and quality of life in older adults with gastroesophageal cancer.
October 16, 2025
|
2 min read
Cancer
Why screening is so important, plus other facts about breast cancer
October 15, 2025
|
4 min read
Cancer,
Science & Research
Novel procedure helps treat New Zealand teen with brain cancer
Sophie Clibborn underwent stereotactic laser ablation, a minimally invasive procedure that uses MRI guidance to precisely target the tumor and destroy it with focused laser energy.
October 13, 2025
|
5 min read
Cancer,
Science & Research
Scientists create radiotheranostic approach designed to combat aggressive cancers
UCLA scientists, together with a team of international collaborators, have identified a promising new treatment strategy that can detect, kill and reprogram aggressive, treatment-resistant tumors like osteosarcomas and glioblastoma.
October 8, 2025
|
5 min read
Cancer,
Science & Research
For rapid, precise lung cancer resections, researchers look to a pen
Dr. Bryan Burt of UCLA Health is leading research on new technology for real-time evaluation of surgical tissue.
October 6, 2025
|
4 min read
Cancer,
Science & Research
Short-course radiation therapy after prostate surgery helps keep cancer from returning
Investigators found that SBRT, a form of high-dose radiation delivered in just five sessions, after prostate surgery is safe and as effective as traditional, longer courses of radiation in preventing prostate cancer from returning.
October 2, 2025
|
3 min read